TSW
IMGN

Thompson Siegel & Walmsley’s Immunogen Inc IMGN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-42,000
Closed -$793K – 559
2023
Q2 		$793K Buy
+42,000
New +$496K 0.01% 285
2017
Q1 		– Sell
-70
Closed – – 970
2016
Q4 		$0 Buy
+70
New +$141 ﹤0.01% 915

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thompson Siegel & Walmsley's IMGN Position: Q3 2023 in Review

Thompson Siegel & Walmsley sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 42,000 shares — an estimated $793K sold.

Thompson Siegel & Walmsley first reported a position in IMGN in Q4 2016 and held it in 2 quarters. The position peaked at $793K in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • Thompson Siegel & Walmsley reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 42,000 Immunogen Inc shares in Q3 2023, an estimated $793K.
  • Thompson Siegel & Walmsley first reported a position in Immunogen Inc in Q4 2016 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's Immunogen Inc position peaked at $793K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2023, filed 8 Nov 2023.